triiodothyronine has been researched along with Benign Intracranial Hypertension in 4 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of benign intracranial hypertension occurring during thyreostimulin suppression hormonotherapy after thyroidectomy for papillary cancer." | 1.31 | Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. ( Conrath, J; Disdier, P; Dufour, H; Granel, B; Henry, JF; Serratrice, J; Weiller, PJ, 2002) |
| "A male patient is reported with benign intracranial hypertension, who presented with three periods of partial pituitary deficiency, corresponding to episodes of headaches and papilledema." | 1.29 | Benign intracranial hypertension as a cause of transient partial pituitary deficiency. ( Abs, R; Clemens, A; De Paepe, L; Louis, P; Martin, JJ; Smets, RM; Verlooy, J, 1993) |
| "The syndrome of benign intracranial hypertension cannot therefore be considered entirely benign and patients should receive full endocrinological assessment and follow up." | 1.26 | Is "benign intracranial hypertension" really benign? ( Barber, SG; Garvan, N, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serratrice, J | 1 |
| Granel, B | 1 |
| Conrath, J | 1 |
| Dufour, H | 1 |
| Disdier, P | 1 |
| Henry, JF | 1 |
| Weiller, PJ | 1 |
| Barber, SG | 1 |
| Garvan, N | 1 |
| De Paepe, L | 1 |
| Abs, R | 1 |
| Verlooy, J | 1 |
| Clemens, A | 1 |
| Smets, RM | 1 |
| Louis, P | 1 |
| Martin, JJ | 1 |
| Soelberg Sørensen, P | 1 |
| Gjerris, F | 1 |
| Svenstrup, B | 1 |
4 other studies available for triiodothyronine and Benign Intracranial Hypertension
| Article | Year |
|---|---|
Benign intracranial hypertension and thyreostimulin suppression hormonotherapy.
Topics: Adenocarcinoma, Papillary; Drug Therapy, Combination; Female; Glycoproteins; Humans; Middle Aged; Pa | 2002 |
Is "benign intracranial hypertension" really benign?
Topics: Adult; Blood Glucose; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydro | 1980 |
Benign intracranial hypertension as a cause of transient partial pituitary deficiency.
Topics: Adult; Follicle Stimulating Hormone; Hormones; Humans; Hypopituitarism; Intracranial Pressure; Lutei | 1993 |
Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid.
Topics: Adolescent; Adult; Arginine Vasopressin; Estrogens; Female; Follicle Stimulating Hormone; Growth Hor | 1986 |